---

10/16/2008	The Federal Circuit Cipro Decision: Another Blow to the FTC's Fight Against Reverse Payment Settlements
12/03/2007	Dolly Not Yet Turned To Lolly
11/14/2007	Morrison & Foerster Advises Oxford Immunotec on $40 million Financing Round Deal is largest financing round for 2 years for a European diagnostics company
11/14/2007	Morrison & Foerster Advises Maelor plc on Exclusive Licensing Agreement with Helsinn Healthcare SA
11/13/2007	Biotechs: Show Me the Money
08/08/2007	Morrison & Foerster Advises ReNeuron Group plc on U.S. Stem Cell Acquisition
07/27/2007	Patent Reform Act of 2007
07/16/2007	Morrison & Foerster Advises GW Pharmaceutical on Global Cannabinoid Research Collaboration
07/13/2007	Biotechs: Recent VC Exit Trends
07/13/2007	Morrison & Foerster Advises Intercell on Worldwide Vaccines Deal
04/05/2007	Morrison & Foerster Advises on Pipeline Boosting Life Science Deals Further deals this year reflect the industry trend
02/20/2007	Morrison & Foerster Advises Acambis Plc €30 Million Partnership Agreement with sanofi pasteur
02/20/2007	Morrison & Foerster Advises GW on $273 Million Strategic Alliance with Otsuka
02/20/2007	Morrison & Foerster Advises ReNeuron Group plc on £5.5 Million Placing
12/12/2006	Venture Capital Investment in the Life Sciences Industry
06/01/2006	World Competition Law and Economics Review: R&D Cooperation, Licensing and Marketing in the Biotechnology Field - EC Competition Law Aspects
07/14/2005	Merck v. Integra: The Supreme Court Holds That the § 271(e)(1) Safe Harbor Extends to Preclinical Studies Intellectual Property Newsletter, Volume 1, No. 2
06/02/2005	SmithKline: How the Expanding Inherent Anticipation Doctrine Affects Chemical Patents Court of Appeals for the Federal Circuit, Decided: April 8, 2005
11/17/2004	Disclose Government-Funded Inventions or Else!
05/18/2004	Judgment of European Court of Justice in IMS Health v. NDC Health
01/28/2004	Burying the "Equity Stake" Theory of Patent Damages
06/10/2003	Europe to Join Japan and the US -- a Bolar Exemption in Europe?
02/04/2003	Federal Circuit Clarifies Written Description Requirements for Certain Biological Materials and Finds a Rebuttable Presumption of Enablement for Both Claimed and Unclaimed Disclosures in Prior Art Patents
08/15/2002	Federal Circuit Restates Law of Written Description for Biotech Patents